A prognostic model in patients who receive chemotherapy for metastatic or recurrent gastric cancer: validation and comparison with previous models.
about
Determination of prognostic factors in Japanese patients with advanced gastric cancer using the data from a randomized controlled trial, Japan clinical oncology group 9912.Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data from the SPIRITS and G-SOX trials.Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers.Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient DataPrognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric CancerPalliative gastrectomy is beneficial in selected cases of metastatic gastric cancer.A Prognostic Model in Metastatic or Recurrent Gastric Cancer Patients with Good Performance Status Who Received First-Line Chemotherapy.Metastatic gastric cancer treatment: a little slow but worthy progress.Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment.Population-based outcomes research on treatment patterns and impact of chemotherapy in older patients with metastatic gastric cancer.Long-term outcomes and prognostic factors of patients with advanced gastric cancer treated with S-1 plus cisplatin combination chemotherapy as a first-line treatment.Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer.Randomized Phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106).Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study.A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites.Role of patient-, tumor- and systemic inflammatory response-related factors in predicting survival of patients with node-negative gastric cancer.Fluoropyrimidine plus cisplatin for patients with advanced or recurrent gastric cancer with peritoneal metastasis
P2860
Q30785622-4BD3CFCE-71E4-4EFE-A4FC-3B72553E97A7Q31162395-7A0EDDE9-0E46-412E-BAF0-C83E4C77C4B4Q33779701-99C5CFAF-FC49-43D3-B349-D79DBE6C75AFQ33849290-E14A7F99-A85D-4E02-B269-DC4C519672F2Q35663782-7D50B16B-1462-4BA3-AF35-97A0A2D94E56Q36306641-30E5CBC5-CD72-42CA-A3EF-1CBFF529A585Q37004336-D5677473-9B28-4DEE-AFEA-64C3E3B57DD2Q38075499-8A6C97FB-5838-4372-8110-E857DDEC2777Q38614739-A429503A-218D-4ABE-ABC8-58EAA6F969FCQ38633055-2CC78D8D-EDB3-4104-A73E-452056093E51Q43485654-F2556BC1-D430-47D0-B27B-E1A152A1A103Q44125251-8E900B89-B3CD-486A-85E4-D7F47A3F5A65Q45350326-1E8C6759-4861-4B1F-948F-F08FCF5DAE98Q46350650-CA0EC0E1-EB60-4FB0-A4EE-2FEC9AABE438Q47425148-6A60BB94-EAA7-41B1-86EC-9980D75BCD77Q49302498-975AD8F2-2344-459A-B5FF-7B048E2DBE0EQ50582885-5D167C10-3313-406D-BC65-775A7AD0BF4AQ57918124-5E4928BB-D49B-4CDA-A9A9-D14EA5E6CA43
P2860
A prognostic model in patients who receive chemotherapy for metastatic or recurrent gastric cancer: validation and comparison with previous models.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A prognostic model in patients ...... mparison with previous models.
@en
type
label
A prognostic model in patients ...... mparison with previous models.
@en
prefLabel
A prognostic model in patients ...... mparison with previous models.
@en
P2093
P2860
P1476
A prognostic model in patients ...... mparison with previous models.
@en
P2093
Baek-Yeol Ryoo
Heung-Moon Chang
Hwa Jung Kim
Jae-Lyun Lee
Jung-Hwa Moon
Min-Hee Ryu
Sung-Sook Lee
Tae Won Kim
Yoon-Koo Kang
P2860
P2888
P304
P356
10.1007/S00280-011-1561-8
P50
P577
2011-02-03T00:00:00Z
P6179
1033527766